Press release


19/10/2012
Merck Serono and Auxogyn Announce Partnership in Test Eeva ™
Logo
The Feasibility Assessment Test early embryo (Test Eeva ™) is designed to provide data to help assess embryo viability.
This strategic partnership demonstrates the strong commitment of Merck Serono to continue investing in assisted reproductive technologies.
 
 
 
Related links:
 
 
Permalink  
 
Developed by Web4Bio